Read the 2024 SABCS® Takeaways
January 23, 2025
Flip through the 2024 SABCS® Takeaways publication to catch up on highlights from the recent San Antonio Breast Cancer Symposium®. Look back on important research and practice discussions across medical oncology, surgical oncology, radiation oncology, and more.
-
View from the Trenches panelists share thoughts on translating SABCS® presentations into practice
Read More: View from the Trenches panelists share thoughts on translating SABCS® presentations into practiceExperts wrapped up the 2024 San Antonio Breast Cancer Symposium® by discussing updates from the week that may have an immediate impact for patients and physicians.
-
Year in Review session summarizes important breast cancer takeaways from 2024
Read More: Year in Review session summarizes important breast cancer takeaways from 2024Neil Vasan, MD, PhD; Pedram Razavi, MD, PhD; Janice Tsang, MBBS, MRCP, FRCP; and Michael A. Danso, MD, highlighted recent developments across breast cancer research and care.
-
Special Session explores considerations behind breast cancer drug approvals, trials
Read More: Special Session explores considerations behind breast cancer drug approvals, trialsPanelists discussed recent U.S. Food and Drug Administration approvals, plus the importance of monitoring ovarian toxicity in breast cancer clinical trials.
-
Experts review approaches to reducing obesity-related risk for breast cancer
Read More: Experts review approaches to reducing obesity-related risk for breast cancerPresenters focused on the mechanisms linking obesity to breast cancer risk and discussed modifiable factors such as body weight, dietary patterns, and physical activity.
-
General Session 3 includes results from ZEST study, analysis from TAILORx trial
Read More: General Session 3 includes results from ZEST study, analysis from TAILORx trialNicholas Turner, MD, PhD; Nan Chen, MD; and Pedram Razavi, MD, PhD, were among eight experts reporting results Friday during the third and final General Session of the 2024 San Antonio Breast Cancer Symposium®.
-
Plenary lecturer: Human Breast Cell Atlas charts pathway from healthy tissue to cancer
Read More: Plenary lecturer: Human Breast Cell Atlas charts pathway from healthy tissue to cancerWalid Khaled, PhD, on Friday discussed work to draw a map of how the breast changes during tumorigenesis and progression.
Presenter Profiles
-
Risk Reduction and Early Detection: The Future of Cancer Genetics Is Here — Presenter Profile
Read More: Risk Reduction and Early Detection: The Future of Cancer Genetics Is Here — Presenter ProfileFergus Couch, PhD, discusses a presentation in a Thursday afternoon Risk Reduction and Early Detection session.
-
Clinical Controversies: Omission of Axillary Staging in ER ER-Positive Cancer: Implications on Adjuvant Therapies — Presenter Profile
Read More: Clinical Controversies: Omission of Axillary Staging in ER ER-Positive Cancer: Implications on Adjuvant Therapies — Presenter ProfileKevin Kalinsky, MD, MS, discusses a presentation in a Thursday afternoon Clinical Controversies session.
-
Educational Session 5: Unlocking New Targets with Molecular Degraders — Presenter Profile
Read More: Educational Session 5: Unlocking New Targets with Molecular Degraders — Presenter ProfileStephen M. Hinshaw, PhD, discusses a presentation in a Wednesday afternoon educational session.